Literature DB >> 35228502

Genome Recombination between the Delta and Alpha Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

Tsuyoshi Sekizuka1, Kentaro Itokawa1, Masumichi Saito2, Michitsugu Shimatani3, Shutoku Matsuyama4, Hideki Hasegawa4, Tomoya Saito2, Makoto Kuroda1.   

Abstract

Prominent genomic recombination has been observed between the Delta and Alpha variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), isolated from clinical specimens in Japan. Interestingly, the recombination variant detected in this study carries a spike protein identical to that in the domestic Delta variant, thereby suggesting that further risks would not be associated with infectivity and immune escape. The recombinant was classified as an XC lineage in the PANGOLIN database. It is necessary to intensively study such marked genetic variations and characterize emerging variants after careful verification of their lineage and clade assignment.

Entities:  

Keywords:  SARS-CoV-2; alpha variant; delta variant; genome recombination

Mesh:

Year:  2022        PMID: 35228502     DOI: 10.7883/yoken.JJID.2021.844

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   2.541


  4 in total

Review 1.  Recombination in Coronaviruses, with a Focus on SARS-CoV-2.

Authors:  Daniele Focosi; Fabrizio Maggi
Journal:  Viruses       Date:  2022-06-07       Impact factor: 5.818

2.  Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.

Authors:  Daichi Yamasoba; Izumi Kimura; Hesham Nasser; Yuhei Morioka; Naganori Nao; Jumpei Ito; Keiya Uriu; Masumi Tsuda; Jiri Zahradnik; Kotaro Shirakawa; Rigel Suzuki; Mai Kishimoto; Yusuke Kosugi; Kouji Kobiyama; Teppei Hara; Mako Toyoda; Yuri L Tanaka; Erika P Butlertanaka; Ryo Shimizu; Hayato Ito; Lei Wang; Yoshitaka Oda; Yasuko Orba; Michihito Sasaki; Kayoko Nagata; Kumiko Yoshimatsu; Hiroyuki Asakura; Mami Nagashima; Kenji Sadamasu; Kazuhisa Yoshimura; Jin Kuramochi; Motoaki Seki; Ryoji Fujiki; Atsushi Kaneda; Tadanaga Shimada; Taka-Aki Nakada; Seiichiro Sakao; Takuji Suzuki; Takamasa Ueno; Akifumi Takaori-Kondo; Ken J Ishii; Gideon Schreiber; Hirofumi Sawa; Akatsuki Saito; Takashi Irie; Shinya Tanaka; Keita Matsuno; Takasuke Fukuhara; Terumasa Ikeda; Kei Sato
Journal:  Cell       Date:  2022-05-02       Impact factor: 66.850

3.  SARS-CoV-2 Delta-Omicron Recombinant Viruses, United States.

Authors:  Kristine A Lacek; Benjamin L Rambo-Martin; Dhwani Batra; Xiao-Yu Zheng; Norman Hassell; Hitoshi Sakaguchi; Thomas Peacock; Natalie Groves; Matthew Keller; Malania M Wilson; Mili Sheth; Morgan L Davis; Mark Borroughs; Jonathan Gerhart; Samuel S Shepard; Peter W Cook; Justin Lee; David E Wentworth; John R Barnes; Rebecca Kondor; Clinton R Paden
Journal:  Emerg Infect Dis       Date:  2022-05-12       Impact factor: 16.126

4.  Sequential Appearance and Isolation of a SARS-CoV-2 Recombinant between Two Major SARS-CoV-2 Variants in a Chronically Infected Immunocompromised Patient.

Authors:  Emilie Burel; Philippe Colson; Jean-Christophe Lagier; Anthony Levasseur; Marielle Bedotto; Philippe Lavrard-Meyer; Pierre-Edouard Fournier; Bernard La Scola; Didier Raoult
Journal:  Viruses       Date:  2022-06-10       Impact factor: 5.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.